96 related articles for article (PubMed ID: 14595558)
1. Health economic issues of screening programmes.
Wildner M
Eur J Pediatr; 2003 Dec; 162 Suppl 1():S5-7. PubMed ID: 14595558
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in Libya.
Sladkevicius E; Pollitt RJ; Mgadmi A; Guest JF
Appl Health Econ Health Policy; 2010; 8(6):407-20. PubMed ID: 21043542
[TBL] [Abstract][Full Text] [Related]
3. [Comparative presentation of current economic evaluation studies for phenylketonuria screening].
Ahrens D; Güntert B; Brand A
Gesundheitswesen; 1999 Apr; 61(4):190-6. PubMed ID: 10408146
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of cost-benefit ratio of neonatal screening procedure for phenylketonuria and hypothyroidism.
Dhondt JL; Farriaux JP; Sailly JC; Lebrun T
J Inherit Metab Dis; 1991; 14(4):633-9. PubMed ID: 1749228
[TBL] [Abstract][Full Text] [Related]
5. [A cost-benefit evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism].
Gu X; Wang J; Ye J; Cheng X
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):147-9. PubMed ID: 11860921
[TBL] [Abstract][Full Text] [Related]
6. Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria.
Lord J; Thomason MJ; Littlejohns P; Chalmers RA; Bain MD; Addison GM; Wilcox AH; Seymour CA
J Epidemiol Community Health; 1999 Mar; 53(3):179-86. PubMed ID: 10396496
[TBL] [Abstract][Full Text] [Related]
7. [Programs of systematic screening in neonatology. Pharmaco-economic aspects].
Schoos R; Verloes A; Bourguignon JP; Koulischer L
Rev Med Liege; 1998 May; 53(5):311-5. PubMed ID: 9689890
[TBL] [Abstract][Full Text] [Related]
8. Expanded newborn screening using tandem mass spectrometry.
Fearing MK; Levy HL
Adv Pediatr; 2003; 50():81-111. PubMed ID: 14626484
[No Abstract] [Full Text] [Related]
9. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism.
Geelhoed EA; Lewis B; Hounsome D; O'leary P
J Paediatr Child Health; 2005 Nov; 41(11):575-9. PubMed ID: 16398841
[TBL] [Abstract][Full Text] [Related]
11. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
[TBL] [Abstract][Full Text] [Related]
12. [Whole-genome sequencing in German clinical practice : Economic impacts of its use in selected areas of application].
Plöthner M; Frank M; Graf von der Schulenburg JM
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Feb; 60(2):143-150. PubMed ID: 27999872
[TBL] [Abstract][Full Text] [Related]
13. [A short-term diagnostic and economic impact model of neonatal screening for cystic fibrosis].
Rasch A; Perleth M
Klin Padiatr; 2011 Mar; 223(2):96-103. PubMed ID: 21305445
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness and test-performance factors in relation to universal newborn hearing screening.
Gorga MP; Neely ST
Ment Retard Dev Disabil Res Rev; 2003; 9(2):103-8. PubMed ID: 12784228
[TBL] [Abstract][Full Text] [Related]
15. [Economic analysis of neonatal screening for drepanocytosis in metropolitan France].
Le Galès C; Galactéros F
Rev Epidemiol Sante Publique; 1994; 42(6):478-92. PubMed ID: 7816961
[TBL] [Abstract][Full Text] [Related]
16. Cost of treatment of congenital dislocation of the hip.
Kernohan G; Trainor B; Mollan R; Normand C
Int J Health Plann Manage; 1991; 6(3):229-33. PubMed ID: 10116625
[TBL] [Abstract][Full Text] [Related]
17. Ethics, evidence, and cost in newborn screening.
Baily MA; Murray TH
Hastings Cent Rep; 2008; 38(3):23-31. PubMed ID: 18581934
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound screening of the neonatal hip: cost-benefit analysis.
Bralić I; Vrdoljak J; Kovacić L
Croat Med J; 2001 Apr; 42(2):171-4. PubMed ID: 11259740
[TBL] [Abstract][Full Text] [Related]
19. Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data.
Clément MC; Mahlaoui N; Mignot C; Le Bihan C; Rabetrano H; Hoang L; Neven B; Moshous D; Cavazzana M; Blanche S; Fischer A; Audrain M; Durand-Zaleski I
J Allergy Clin Immunol; 2015 Jun; 135(6):1589-93. PubMed ID: 25840725
[TBL] [Abstract][Full Text] [Related]
20. The high price of false positives.
Howell RR
Mol Genet Metab; 2006 Mar; 87(3):180-3. PubMed ID: 16325443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
